🌐 Website Architecture & Navigation
HTML Sitemap Directory
Explore all 47 indexed pages, commercial API products, finished formulations, specialty intermediates, regulatory dossiers, and industry articles across the PEC Pharma ecosystem.
🔍
🏢
Company & Information
7 URLs
Home PageOverview, hero highlights, client network & certifications
CoreAbout PEC PharmaCorporate story, leadership, R&D and Saykha plant
AboutQuality & GMP ComplianceICH Q3A/B standards, QC analytical lab & DMFs
QualityTherapeutic AreasCNS, Respiratory, Cardiovascular, Urology, ENT
AreasGlobal PresenceExporting to LATAM, CIS, SEA, South Asia & Africa
GlobalCareers at PEC PharmaOpen roles in R&D, QA, QC and Regulatory Affairs
HiringContact UsEnquiries, sample requests, quotes & facility addresses
Contact🧪
Product Portfolios & Services
6 URLs
Product Ecosystem OverviewFull range of APIs, formulations, intermediates & CDMO
OverviewComplex Active Pharmaceutical IngredientsCommercial APIs and scale-up molecules with DMF
APIsFinished FormulationsTablets, capsules, oral liquids & injectables (50+ dossiers)
FormulationsSpecialty Intermediates27+ chemical intermediates with documented CAS numbers
IntermediatesCRDMO & CDMO ServicesCryogenic reactions (-80°C), kilo lab & commercial scaling
ServicesPharmaceutical ImpuritiesReference standards, nitroso impurities & analytical COA/NMR
Standards🧭
Therapeutic Area Hubs
4 URLs
CNS & NeuropsychiatricCNS and neuropsychiatric APIs from PEC Pharma including Lacosamide, Bupropion HCl, Acamprosate, Mirtazapine, Pramipexole and Topiramate — Gujarat, India.
TherapeuticUrologyUrology APIs from PEC Pharma including Silodosin (BPH alpha-blocker) and Sildenafil Citrate — commercial and development programmes from Gujarat, India.
TherapeuticRespiratory & ENTRespiratory and ENT APIs from PEC Pharma: Xylometazoline HCl and Oxymetazoline HCl for nasal formulations, with GMP supply from Gujarat.
TherapeuticGastrointestinalGastrointestinal APIs from PEC Pharma, including Omeprazole, Lansoprazole and Bisacodyl, for GI formulation partners in India.
Therapeutic💊
Commercial Active Pharmaceutical Ingredients (APIs)
17 URLs
Acamprosate Calcium APICAS 77337-73-6 • Alcohol Deterrents
CommercialXylometazoline HCL APICAS 1218-35-5 • Topical Nasopharyngeal
CommercialOxymetazoline HCL APICAS 2315-02-8 • Topical Nasopharyngeal
CommercialBupropion HCL APICAS 31677-93-7 • Antidepressant
CommercialLacosamide APICAS 175481-36-4 • Antiepileptic
CommercialSilodosin APICAS 160970-54-7 • Alpha-Blocker (BPH)
CommercialMirtazapine APICAS 85650-52-8 • Antidepressant
Under Scale-Up / R&DPramipexole Di-HCL APICAS 191217-81-9 • Dopamine Agonists
Under Scale-Up / R&DLinezolid APICAS 165800-03-3 • Antibiotic
Under Scale-Up / R&DDimethyl Fumarate APICAS 624-49-7 • Immunomodulators
Under Scale-Up / R&DBaclofen APICAS 1134-47-0 • Antispasmodic
Under Scale-Up / R&DBisacodyl APICAS 603-50-9 • Stimulant Laxative
Under Scale-Up / R&DSildenafil Citrate APICAS 171599-83-0 • Erectile Dysfunction
Under Scale-Up / R&DTopiramate APICAS 97240-79-4 • Anticonvulsants
Under Scale-Up / R&DOmeprazole APICAS 73590-58-6 • Gastrointestinal Agent
Under Scale-Up / R&DLansoprazole APICAS 103577-45-3 • Gastrointestinal Agent
Under Scale-Up / R&DCilostazol APICAS 73963-72-1 • Anticoagulant
Under Scale-Up / R&D📰
Articles & Industry Insights
7 URLs
All Blog Articles & NewsTechnical updates, GMP guidelines & regulatory news
NewsAdvancements in Complex API ManufacturingExploring the latest breakthroughs in continuous flow chemistry and how it is revolutionizing the production of complex active pharmaceutical ingredients.
ArticleGMP Compliance: Meeting Global StandardsA deep dive into our quality control processes at the GIDC Saykha facility and how we maintain compliance with stringent pharmacopoeial schedules.
ArticleExpanding Our Reach in LATAM MarketsPEC Pharma announces new dossier filings and strategic partnerships to supply finished formulations across Latin America.
ArticleOvercoming Challenges in Stereoselective SynthesisDetailed review of chiral separation techniques implemented in our R&D labs to secure high enantiomeric purity in complex molecules like Bupropion.
ArticleRegulatory Readiness for European MarketsAs we expand our API dossier filings, read about our proactive steps to ensure compliance with EMA expectations for upcoming submissions.
ArticleThe Role of Reference Standards in API Impurity ProfilingHow deeply characterized analytical reference materials are critical to mitigating nitroso impurity risks and satisfying ICH Q3A/Q3B guidelines.
Article📄
Regulatory Documents & Certificates
4 URLs
🤖
Search Engine Crawlers & System Files
2 URLs